Stamos Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $852K | Buy |
7,683
+59
| +0.8% | +$6.54K | 0.15% | 119 |
|
|
2025
Q1 | $854K | Sell |
7,624
-5,826
| -43% | -$653K | 0.22% | 110 |
|
|
2024
Q4 | $1.24M | Sell |
13,450
-19,510
| -59% | -$1.8M | 0.29% | 99 |
|
|
2024
Q3 | $2.76M | Sell |
32,960
-10,350
| -24% | -$868K | 0.65% | 41 |
|
|
2024
Q2 | $2.97M | Buy |
43,310
+6,750
| +18% | +$463K | 0.63% | 37 |
|
|
2024
Q1 | $2.68M | Buy |
36,560
+5,960
| +19% | +$437K | 0.61% | 40 |
|
|
2023
Q4 | $2.48M | Sell |
30,600
-14,710
| -32% | -$1.19M | 0.67% | 44 |
|
|
2023
Q3 | $3.4M | Buy |
45,310
+870
| +2% | +$65.2K | 0.76% | 36 |
|
|
2023
Q2 | $3.42M | Buy |
44,440
+7,020
| +19% | +$541K | 0.8% | 32 |
|
|
2023
Q1 | $3.1M | Buy |
37,420
+5,670
| +18% | +$470K | 0.8% | 37 |
|
|
2022
Q4 | $2.73M | Sell |
31,750
-15,900
| -33% | -$1.37M | 0.86% | 32 |
|
|
2022
Q3 | $2.94M | Buy |
47,650
+26,450
| +125% | +$1.63M | 0.75% | 40 |
|
|
2022
Q2 | $1.31M | Hold |
21,200
| – | – | 0.4% | 51 |
|
|
2022
Q1 | $1.26M | Buy |
+21,200
| New | +$1.26M | 0.42% | 44 |
|
|
2021
Q1 | – | Sell |
-50,700
| Closed | -$2.95M | – | 48 |
|
|
2020
Q4 | $2.95M | Buy |
+50,700
| New | +$2.95M | 1.26% | 27 |
|
|
2020
Q2 | – | Sell |
-13,454
| Closed | -$1.01M | – | 72 |
|
|
2020
Q1 | $1.01M | Buy |
+13,454
| New | +$1.01M | 0.53% | 58 |
|
|
2019
Q3 | – | Sell |
-3,600
| Closed | -$244K | – | 47 |
|
|
2019
Q2 | $244K | Buy |
+3,600
| New | +$244K | 0.24% | 50 |
|